FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Download PDF Copy

Oct 11 2010

NewsGuard 100/100 Score

Warner Chilcott plc (Nasdaq: WCRX) today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.

"The approval of ATELVIA represents an exciting addition to the ACTONEL franchise, as well as our women's healthcare product portfolio. We believe the dosing convenience of ATELVIA sets it apart from other treatment options for osteoporosis patients and provides an opportunity to regain market share in the U.S. in this segment," said Roger Boissonneault, President and CEO of Warner Chilcott.

The Company anticipates the commercial launch of ATELVIA in early 2011.

Source:

Warner Chilcott plc

Posted in: Women's Health News | Pharmaceutical News

Tags: Bisphosphonate, Dermatology, Food, Gastroenterology, Healthcare, Next Generation, Osteoporosis, Urology

Comments (0)

Download PDF Copy

Suggested Reading

$Severe mental illness linked to higher risk of fragility fractures in older adults$

Severe mental illness linked to higher risk of fragility fractures in older adults

New global analysis highlights micronutrient shortages

New global analysis highlights micronutrient shortages

KAUST researchers uncover LINE-1 RNA’s role in triggering bone repair

KAUST researchers uncover LINE-1 RNA’s role in triggering bone repair

Later menopause linked to increased asthma risk in women

Later menopause linked to increased asthma risk in women

Fermented foods' health impacts analyzed in groundbreaking European study

Fermented foods' health impacts analyzed in groundbreaking European study

$Gut microbiota linked to fracture risk: Study reveals key microbial associations$

Gut microbiota linked to fracture risk: Study reveals key microbial associations

Vitamin D supplements during pregnancy strengthen children's bones

Vitamin D supplements during pregnancy strengthen children's bones

Machine learning identifies key genes linking rheumatoid arthritis and osteoporosis

Machine learning identifies key genes linking rheumatoid arthritis and osteoporosis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

How do animal and plant-based milks affect gut health?